Geisinger Health System Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk The health system will partner with the NCI to look for new cancer risk variants in a large population biobank, in the hopes of improving screening and care. Exome Sequencing Provides Molecular Diagnosis in Portion of Cerebral Palsy Cases A Geisinger and GeneDx team found exome sequencing can lead to a molecular diagnosis for 10 percent to 33 percent of people with cerebral palsy. Geisinger National Experts Join Genome Medical to Help Implement Population Genomics Programs Premium The Geisinger National Precision Health Initiative ended in 2019 but its leaders joined Genome Medical to bring genomics-informed care to other health systems. Chatbots Could Help Human Genetic Counselors Focus on Patient Concerns Panelists at the NSGC annual meeting said artificial intelligence approaches like chatbots could complement traditional genetic counseling approaches. Dilated Cardiomyopathy Risk Increased in Only Some With Titin Truncations Geisinger and UPenn researchers found that Titin truncations revealed by exome sequencing increased DCM risk in those with European but not with African ancestry. May 20, 2019 Startup GenomeSmart to Address Lack of Genetic Testing Knowledge With Digital Solution Premium Feb 28, 2019 Geisinger, Johns Hopkins Testing Liquid Biopsy Assay for Early Cancer Detection Jan 8, 2019 JP Morgan Healthcare, Day One: 10x Genomics, Myriad, Bruker, Konica Minolta, Geisinger Nov 19, 2018 At NSGC, Genetic Counselors Discuss Why, How Gene Variants Are Reclassified Sep 25, 2018 Geisinger Deploys 'Gia' Chatbot to Help Genetic Counselors Manage MyCode Participants Premium Sep 21, 2018 Geisinger Exome Study IDs Breast Cancer Risk Variants That May Not Have Been Detected in Routine Care Sep 11, 2018 Yale to Launch Large-Scale Genomic Medicine Project Premium Aug 9, 2018 Geisinger Team Describes Approach for Returning Secondary Genomic Findings to Research Participants Jun 29, 2018 Reassessment of Genes' Links to Brugada Syndrome Finds Only One With Definitive Evidence May 7, 2018 Geisinger Health System to Launch Free Clinical Exome Sequencing Pilot to Predict Disease Risk Premium Jan 26, 2018 Large-Scale Sequencing Projects Navigate Grey Area Between Research, Clinical Testing Premium Nov 16, 2017 Regeneron Says Large-Scale Human Genetics Starting to Generate New Drug Targets Premium Nov 16, 2017 Geisinger Experience Implementing Precision Medicine Spurs New Effort to Help Others Do the Same Premium Sep 27, 2017 Clear Genetics Developing Chatbot to Triage, Supplement Genetic Counseling Premium Jul 26, 2017 Helix Launches Genomics App Store, but Will Consumers Pay? May 26, 2017 ClinGen Team Presents Proposed Gene-Disease Association Classification Framework May 25, 2017 Targeting ANGPTL3 Could Lead to Development of Heart Disease Therapies Apr 28, 2017 Penn State, Geisinger Team on New Biomedical Big Data Program Apr 25, 2017 Cancer Genetic Counselors Report Practice Changes After AMP v. Myriad Court Decision Dec 22, 2016 Analysis of Nearly 51,000 Geisinger Patient Exomes, EHRs Reveal Actionable Variants, Drug Targets Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.